Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Laurie Elit

ResearcherPublications, citations & collaboration network

Laurie Elit is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 204 works, 7,250 citations, an h-index of 40 and an i10-index of 92.

204
Works
7,250
Citations
40
h-index
92
i10-index

How has Laurie Elit's publication output changed over time?

ScholarIQpublication output · 2006–2022

Output grew0% over the shown period — from 1 works in 2006 to 1 in 2022.

1
2
1
1
3
1
1
1
20062007200820092011201720182022

What are the most-cited papers on Laurie Elit?

ScholarIQmost cited works
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert L. Coleman, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Léary, Robert W. Holloway, Margarita Amenedo, Peter C.C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Jesús García-Donás, Elizabeth M. Swisher, Anne Floquet, Gottfried E. Konecny, Iain A. McNeish, Clare L. Scott, T. Cameron, Lara Maloney, Jeff Isaacson, Sandra Goble, Caroline A. Grace, Thomas C. Harding, Mitch Raponi, James Sun, Kevin Lin, Heidi Giordano, Jonathan A. Ledermann, Martin Buck, Andrew Dean, Michael Friedländer, Jeffrey C. Goh, Paul R. Harnett, Ganessan Kichenadasse, Clare L. Scott, Hannelore Denys, Luc Dirix, Ignace Vergote, Laurie Elit, Prafull Ghatage, Amit M. Oza, Marie Plante, Diane Provencher, Johanne I. Weberpals, Stephen Welch, Anne Floquet, Laurence Gladieff, Florence Joly, Alexandra Léary, Alain Lortholary, Jean‐Pierre Lotz, Jacques Médioni, Olivier Trédan, Benoît You, Ayşe Balat, Claudia Hänle, Petra Krabisch, Tanja Neunhöffer, Martin Pölcher, Pauline Wimberger, A Amit, Svetlana Kovel, Michelle Leviov, Tamar Safra, Ronnie Shapira‐Frommer, Salomon M. Stemmer, Alessandra Bologna, Nicoletta Colombo, Domenica Lorusso, Sandro Pignata, Roberto Sabbatini, Giovanni Scambia, Stefano Tamberi, Claudio Zamagni, Peter C.C. Fong, Anne O’Donnell, Margarita Amenedo, A. Casado Herráez, Jesús García-Donás, E.M. Guerra, Ana Oaknin, Isabel Palacio, Ignacio Romero, A Sanchez, Susana Banerjee, Andrew R. Clamp, Yvette Drew, Hani Gabra, D Jackson, JA Ledermann, Iain A. McNeish, C. A. Parkinson, Melanie Powell, Carol Aghajanian
The Lancet. 20171,721 CitationsOPEN ACCESS
Follow-up after primary therapy for endometrial cancer: A systematic review
Michael Fung‐Kee‐Fung, Jason Dodge, Laurie Elit, Himu Lukka, Alex Chambers, Tom Oliver
Gynecologic Oncology. 2006369 Citations
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Jim Biagi, Diane Provencher, Walter H. Gotlieb, Paul Hoskins, Prafull Ghatage, Katia Tonkin, Helen Mackay, J. Mazurka, Joana Sederias, Percy Ivy, Janet Dancey, Elizabeth A. Eisenhauer
Journal of Clinical Oncology. 2011341 CitationsOPEN ACCESS
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B. Kristensen, Mahesh Parmar, Tom Ehlen, Gordon C. Jayson, Nick Johnson, Ann Marie Swart, René H.M. Verheijen, W. Glenn McCluggage, Timothy Perren, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Gavin Stuart, N.S. Reed, Sean Kehoe, Claes Tropé G., Stephen Dobbs, Sharadah Essapen, P. Hoskins, John Green, Edward D. Gilby, Marchien van Baal, Jeremy Twigg, Maria E.L. van der Burg, Keith Godfrey, Ángel J. Lacave, Roberto Angioli, Rahul Nath, K. Chin, Charles Redman, Robert Lotocki, Adeola Olaitan, Berit Jul Mosgaard, Gordon Rustin, Thomas Ind, Mojca Persic, Martin Hogg, Jacobus van der Velden, Jonathan A. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, Päivi Kannisto, V Hird, Anthony C. Evans, R. Sandvei R., Philippe Gauthier, Derek Cruickshank, P.B. Ottevanger, Sheila E. Pearson, Henry C Kitchener, Marcia Hall, Paul Bessette, S. Pecorelli, Eva Gerdin, Tito Lopes, Andrew Fish, Clare Barlow, Koen Van Eygen, Anne Floquet, Bengt Tholander, Nurdan Gül, Robert Gornall, David Luesley, P. H. Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, M A Hocking, Al Sammaraie, P Speiser, Éric Leblanc, J.A. Green, C Fernández Oliveira, Robert Grimshaw, Paolo Zola, David E. Parkin, David Luesley, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, Marie Plante, B. De Valk, A Nordin, Andrew R. Clamp, D Díaz Pérez, Graham Dark, Michelle Ferguson, Carol MacGregor, G. Skailes, Rachel Jones, Alan Gillespie, G. Cawdell, Simon Leeson
The Lancet Oncology. 2018311 CitationsOPEN ACCESS
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit, Amit M. Oza, Hal W. Hirte, Peter Bryson, on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
Current Oncology. 2007226 CitationsOPEN ACCESS

Related on ScholarIQ

Cameroon Baptist Convention Health Services
Institution
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Paper
Follow-up after primary therapy for endometrial cancer: A systematic review
Paper
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Paper
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Paper
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Paper
470M+ articles · free account